Enveric Biosciences, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Enveric Biosciences, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Enveric Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 8.99M shares, a 312% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.99M +6.81M +312% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 7.88M +5.74M +268% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 7.29M +5.22M +251% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 2.74M +661K +31.8% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 2.18M +104K +4.99% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 2.14M +1.09M +103% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 2.08M -50.5M -96.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 2.08M +1.43M +219% Dec 31, 2022 10-K 2024-03-26
Q3 2022 2.08M -29.3M -93.4% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 1.05M -20.4M -95.1% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 52.6M +33.2M +171% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 652K -9.44M -93.5% Dec 31, 2021 10-K/A 2023-06-09
Q3 2021 31.4M +25.6M +447% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 21.4M +16.3M +315% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 19.4M +16.2M +499% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 10.1M +4.78M +90.1% Dec 31, 2020 10-K 2022-03-31
Q3 2020 5.74M -57.1M -90.9% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 5.16M -47.3M -90.2% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 3.25M -47.1M -93.5% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 5.31M +3.62M +214% Dec 31, 2019 10-K 2021-04-01
Q3 2019 62.8M +39.9M +174% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 52.4M +33.4M +176% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 50.3M +31.5M +168% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 1.69M -16.5M -90.7% Dec 31, 2018 10-K/A 2020-08-12
Q3 2018 22.9M +7.09M +44.7% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 19M +4.36M +29.8% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 18.8M +4.21M +28.9% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 18.2M +4.28M +30.8% Dec 31, 2017 10-K 2019-03-26
Q3 2017 15.9M +2.37M +17.6% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 14.7M +1.16M +8.64% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 14.6M +2.71M +22.8% Mar 31, 2017 10-Q/A 2017-05-15
Q4 2016 13.9M +2.01M +16.9% Dec 31, 2016 10-K 2018-04-02
Q3 2016 13.5M +1.85M +15.9% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 13.5M +1.85M +15.9% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 11.9M +1.88M +18.8% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 11.9M -3.54M -22.9% Dec 31, 2015 10-K/A 2017-04-04
Q3 2015 11.6M -3.77M -24.5% Sep 30, 2015 10-Q 2015-11-23
Q2 2015 11.6M -3.77M -24.5% Jun 30, 2015 10-Q/A 2015-08-18
Q1 2015 9.99M +3.4M +51.5% Mar 31, 2015 10-KT 2016-03-15
Q4 2014 15.4M +3.27M +26.9% Dec 31, 2014 10-Q 2015-05-14
Q3 2014 15.4M +3.27M +26.9% Sep 30, 2014 10-Q/A 2014-11-14
Q2 2014 15.4M +3.27M +26.9% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 6.6M -5.54M -45.7% Mar 31, 2014 10-KT 2016-03-15
Q4 2013 12.1M 0 0% Dec 31, 2013 10-K 2015-03-31
Q3 2013 12.1M 0 0% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 12.1M 0 0% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 12.1M 0 0% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 12.1M +25 0% Dec 31, 2012 10-K 2014-03-28
Q3 2012 12.1M 0 0% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 12.1M +5.64M +86.8% Jun 30, 2012 10-Q 2012-08-01
Q1 2012 12.1M Mar 31, 2012 10-Q/A 2012-05-10
Q4 2011 12.1M +5.64M +86.8% Dec 31, 2011 10-K 2013-02-28
Q3 2011 12.1M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 6.5M Jun 30, 2011 10-Q 2011-08-02
Q4 2010 6.5M Dec 31, 2010 10-K 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.